HAMILTON LANE INC-CLASS A (HLNE)

US4074971064 - Common Stock

115.33  +2.79 (+2.48%)

After market: 115.33 0 (0%)

Fundamental Rating

5

HLNE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 210 industry peers in the Capital Markets industry. While HLNE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. HLNE is valied quite expensively at the moment, while it does show a decent growth rate.



7

1. Profitability

1.1 Basic Checks

In the past year HLNE was profitable.
In the past year HLNE had a positive cash flow from operations.
Each year in the past 5 years HLNE has been profitable.
In the past 5 years HLNE always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 10.23%, HLNE belongs to the top of the industry, outperforming 87.98% of the companies in the same industry.
With an excellent Return On Equity value of 26.41%, HLNE belongs to the best of the industry, outperforming 91.83% of the companies in the same industry.
HLNE has a Return On Invested Capital of 19.26%. This is amongst the best in the industry. HLNE outperforms 95.19% of its industry peers.
HLNE had an Average Return On Invested Capital over the past 3 years of 17.10%. This is significantly above the industry average of 10.69%.
The 3 year average ROIC (17.10%) for HLNE is below the current ROIC(19.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.23%
ROE 26.41%
ROIC 19.26%
ROA(3y)9.82%
ROA(5y)10.32%
ROE(3y)36.25%
ROE(5y)35.7%
ROIC(3y)17.1%
ROIC(5y)22.06%

1.3 Margins

HLNE has a Profit Margin (25.23%) which is comparable to the rest of the industry.
HLNE's Profit Margin has improved in the last couple of years.
The Operating Margin of HLNE (43.10%) is better than 72.60% of its industry peers.
In the last couple of years the Operating Margin of HLNE has declined.
Industry RankSector Rank
OM 43.1%
PM (TTM) 25.23%
GM N/A
OM growth 3Y2.21%
OM growth 5Y-2.07%
PM growth 3Y-1.28%
PM growth 5Y24.67%
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, HLNE has more shares outstanding
Compared to 5 years ago, HLNE has more shares outstanding
HLNE has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 6.26 indicates that HLNE is not in any danger for bankruptcy at the moment.
HLNE's Altman-Z score of 6.26 is amongst the best of the industry. HLNE outperforms 90.38% of its industry peers.
HLNE has a debt to FCF ratio of 1.94. This is a very positive value and a sign of high solvency as it would only need 1.94 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.94, HLNE belongs to the top of the industry, outperforming 80.77% of the companies in the same industry.
HLNE has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
HLNE has a better Debt to Equity ratio (0.42) than 72.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.94
Altman-Z 6.26
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

HLNE has a Current Ratio of 0.71. This is a bad value and indicates that HLNE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.71, HLNE is doing worse than 69.23% of the companies in the same industry.
HLNE has a Quick Ratio of 0.71. This is a bad value and indicates that HLNE is not financially healthy enough and could expect problems in meeting its short term obligations.
HLNE has a worse Quick ratio (0.71) than 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.71

5

3. Growth

3.1 Past

HLNE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.36%.
HLNE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.22% yearly.
HLNE shows a decrease in Revenue. In the last year, the revenue decreased by -5.21%.
The Revenue has been growing by 16.73% on average over the past years. This is quite good.
EPS 1Y (TTM)7.36%
EPS 3Y18.33%
EPS 5Y15.22%
EPS growth Q2Q65.12%
Revenue 1Y (TTM)-5.21%
Revenue growth 3Y24.5%
Revenue growth 5Y16.73%
Revenue growth Q2Q-1.44%

3.2 Future

Based on estimates for the next years, HLNE will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.51% on average per year.
HLNE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.45% yearly.
EPS Next Y9.84%
EPS Next 2Y17.21%
EPS Next 3Y17.51%
EPS Next 5YN/A
Revenue Next Year-3.7%
Revenue Next 2Y5.66%
Revenue Next 3Y8.45%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

HLNE is valuated quite expensively with a Price/Earnings ratio of 32.95.
79.33% of the companies in the same industry are cheaper than HLNE, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of HLNE to the average of the S&P500 Index (28.06), we can say HLNE is valued inline with the index average.
HLNE is valuated quite expensively with a Price/Forward Earnings ratio of 25.21.
71.63% of the companies in the same industry are cheaper than HLNE, based on the Price/Forward Earnings ratio.
HLNE's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 20.72.
Industry RankSector Rank
PE 32.95
Fwd PE 25.21

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HLNE.
Based on the Price/Free Cash Flow ratio, HLNE is valued a bit more expensive than the industry average as 63.46% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 61.38
EV/EBITDA 28.62

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLNE does not grow enough to justify the current Price/Earnings ratio.
HLNE has a very decent profitability rating, which may justify a higher PE ratio.
HLNE's earnings are expected to grow with 17.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.35
PEG (5Y)2.17
EPS Next 2Y17.21%
EPS Next 3Y17.51%

3

5. Dividend

5.1 Amount

HLNE has a Yearly Dividend Yield of 1.57%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 7.30, HLNE is paying slightly less dividend.
HLNE's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.57%

5.2 History

The dividend of HLNE is nicely growing with an annual growth rate of 46.75%!
HLNE has been paying a dividend for over 5 years, so it has already some track record.
As HLNE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)46.75%
Div Incr Years6
Div Non Decr Years6

5.3 Sustainability

HLNE pays out 63.44% of its income as dividend. This is not a sustainable payout ratio.
HLNE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP63.44%
EPS Next 2Y17.21%
EPS Next 3Y17.51%

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (5/2/2024, 7:00:01 PM)

After market: 115.33 0 (0%)

115.33

+2.79 (+2.48%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.23B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.57%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 32.95
Fwd PE 25.21
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.35
PEG (5Y)2.17
Profitability
Industry RankSector Rank
ROA 10.23%
ROE 26.41%
ROCE
ROIC
ROICexc
ROICexgc
OM 43.1%
PM (TTM) 25.23%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.71
Quick Ratio 0.71
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)7.36%
EPS 3Y18.33%
EPS 5Y
EPS growth Q2Q
EPS Next Y9.84%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-5.21%
Revenue growth 3Y24.5%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y